Direct Cloning
AssigneeGene Bridges GMBH
InventorsYouming Zhang, Jun Fu, Adrian Francis Stewart
Life of this patent
Estimating the term…
Abstract
A method for performing homologous recombination between at least a first nucleic acid molecule and a second nucleic acid molecule which share at least one region of sequence homology. A method for improving the efficiency of homologous recombination.
Claims56
A method for performing homologous recombination between at least a first nucleic acid molecule and a second nucleic acid molecule which share at least one region of sequence homology, wherein the method comprises bringing the first nucleic acid molecule into contact with the second nucleic acid molecule in the presence of a 5′ to 3′ exonuclease and an annealing protein;
- wherein the 5′ to 3′ exonuclease comprises a region having 5′ to 3′ exonuclease activity and at least:
- i) amino acids 564-587 of SEQ ID NO:1;
- or
- ii) a 24 amino acid sequence having at least 70% identity to amino acids 564-587 of SEQ ID NO:1 over the entire length of the 24 amino acid sequence.
The method of any one of the preceding claims, wherein the RecE has at least 75%, 80%, 85%, 90%, 95%, 98% or 99% sequence identity to the RecE provided in SEQ ID NO:1.
The method of any one of the preceding claims, wherein the RecE is full-length RecE.
The method of any one of the preceding claims wherein the first and second nucleic acid molecules are linear nucleic acid molecules.
The method of any one of the preceding claims wherein the homologous recombination is carried out in a host cell.
The method of any one of the preceding claims, wherein the second nucleic acid is a linearised cloning vector, such as a linearised BAC, a linearised p15A origin based vector, a linearised pBR322 origin based vector, a linearised fosmid, a linearised pUC origin based vector or a linearised ColE1 origin based vector.
The method of any one of the preceding claims, wherein the first nucleic acid molecule comprises a sequence of interest of 2 kb or more in length.
The method of any one of the preceding claims, wherein the first nucleic acid molecule comprises a sequence of interest which is a gene cluster.
The method of any one of the preceding claims wherein the first nucleic acid molecule is a fragment of genomic DNA.
The method of any one of the preceding claims, wherein the first nucleic acid molecule is a linearised BAC and the method is used to subclone a sequence of interest from the BAC into a cloning vector.
The method of any one of the preceding claims, wherein the at least first and second nucleic acid molecules are linear and the method further comprises using the product of the linear to linear homologous recombination reaction between the at least first and second nucleic acid molecules in a second step of linear to circular homologous recombination in the presence of Redalpha and Redbeta or truncated RecE and RecT.
The method of any one of the previous claims, wherein the first nucleic acid molecule is linear and comprises a phosphorothioation proximal to its 5′ end and a phosphorothioation proximal to its 3′ end.
The method of any one of the preceding claims for generating a cDNA library.
A host cell comprising a recE gene on an integrated prophage, wherein the recE gene is under the control of a heterologous promoter.
A method for improving the efficiency of homologous recombination by performing homologous recombination in the presence of at least one single stranded oligonucleotide that has no sequence homology to the nucleic acid molecules undergoing homologous recombination, wherein the efficiency of homologous recombination is improved relative to when homologous recombination is performed in the absence of the at least one single stranded oligonucleotide.
A method for performing homologous recombination between at least a first nucleic acid molecule and a second nucleic acid molecule which share at least one region of sequence homology, comprising, prior to performing homologous recombination in vivo, the step of linearising at least one circular nucleic acid molecule in vivo using a rare-cutting sequence specific DNA cleaving enzyme to generate the first and/or the second nucleic acid molecule.
Dependencies are inferred from the claim text.